The Wall Street JournalAt $2 Million, New Novartis Drug Is Priciest EverMay 24, 2019Denise RolandBy Denise Rolandmore_vert
The New York TimesThis New Treatment Could Save the Lives of Babies. But It Costs $2.1 Million. (Published 2019)May 24, 2019Katie ThomasBy Katie Thomasmore_vert
FiercePharmaNovartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approveMay 24, 2019Carly HelfandBy Carly Helfandmore_vert
CNBCFDA approves Novartis' $2.1 million gene therapy — making it the world's most expensive drugMay 24, 2019Berkeley Lovelace, Angelica Peebles & Berkeley Lovelace Jr.By Berkeley Lovelace, Angelica Peebles & Berkeley Lovelace Jr.more_vert
NPRZolgensma From Novartis Is The Most Expensive Drug Ever Approved : Shots - Health NewsMay 24, 2019Rob SteinBy Rob Steinmore_vert